Startup Investments

2Morrow’s mission is to help millions improve their lives with the use of evidence-based, behavioral change programs. We do this by creating and distributing leading-edge programs based on the work of respected researchers and thought leaders. 2Morrow delivers these programs directly into the hands of people, whenever and wherever they need them via their smartphone.

A-Alpha Bio has developed a proprietary synthetic biology platform, called AlphaSeq, that enables screening against thousands of targets in a single experimental step. An all-at-once approach saves time, reduces cost, and improves success rates.

Abacus Bioscience is focused on developing novel and game changing immunotherapies for treating chronic infectious diseases and cancers. Abacus is developing a broad-based platform that can plug-and-play with multiple cancer or viral antigens.

Your mission is to deliver better care. But, you can’t fix what you can’t see. AdaptX enables you to transform treatments and workflows by adaptively managing performance.

Deep insights with 3D spatial biology. Alpenglow (formerly Lightspeed Microscopy) sheds new light on tissue analysis with an AI-powered 3D approach. Novel chemistry, a patented high-throughput light-sheet microscope, and cloud-based AI analysis adds a new dimension to your pathology.

Arzeda has the world-leading computational enzyme design technology and is changing the way people think about biocatalysis. Arzeda’s team brings more than 20 years of combined experience in the field of computational and experimental protein engineering.

Automating healthcare contact center operations. BirchAI simplifies work for your highly trained staff, by automating After Call Work and related tasks, with our state-of-the-art artificial intelligence. For Medical Device, Pharma, Payers, and Providers.

BlueDot Photonics makes clean energy available for more people in more places on the pale, blue dot of Earth.

Developing advanced body worn sensing and computing technologies for diagnostic testing in cardiology, respiratory and other complex disease states.

Cyrus solves difficult protein engineering and structure prediction problems using the most scientifically advanced, powerful, and laboratory-proven software tools available. Cyrus’ work is based primarily on the Rosetta molecular modeling and design toolkit first developed at the lab of co-founder David Baker. We are passionate about scientific excellence, operational excellence, and customer success.

DirectAMS provides high-precision radiocarbon dating services for applications in Archaeology, Geology, Anthropology, Climate Science, Antiquities, and more!

Faraday Pharmaceuticals® is a biopharmaceutical company pioneering the use of specific, reduced forms of natural elements — elemental reducing agents — to improve quality of life after acute, critical illness.

While life expectancy has increased, so has the number of years that people live in poor health. A major contributor to decreased quality of life is associated with muscle loss following illnesses such as a heart attack or other emergency health crises.

Our lead therapeutic candidate, FDY-5301, is being evaluated for its potential to minimize damage to cardiac and skeletal muscle.

An elemental approach to better batteries: Group14 uses its unique high performance carbon engineering abilities to create cohesive silicon-carbon nanocomposites that dramatically outperform traditional carbon coated silicons. Our carbon makes any silicon work much better and when combined with our novel, low-cost nano-silicon, Group14 delivers a value proposition better than graphite.

Developing the Next Generation of Essential, Disease-Modifying Medicines

KayoThera is developing first-in-class, oral and safe antagonists of retinoid signaling, a pathway that was previously thought to be undruggable. KayoThera has developed a pipeline of potent drugs that inhibit retinoid signaling, have superb drug-like properties and excellent safety profile. Our retinoid inhibitors could be a potent and long-lasting option to reverse Type 2 diabetes as well as treat a number of genetically-defined cancers.

SMITE cancer.

MajorBoost automates your insurance phone calls and gives you proof. Healthcare workers spend millions of hours chasing down insurance to help patients access the care they need, waiting for an insurance agent, losing precious time. MajorBoost handles the hassle.

The HIPPA Compliance Platform: Protect your organization and your patients’ information. With Medcurity, you can build or complement your HIPAA Privacy and Security program with the most intuitive tools and helpful guidance available.

Membrion has developed breakthrough Molecular Self Assembly (MSA) technology that uses readily available, non-toxic and low-cost materials to produce advanced ceramic ion exchange membranes which perform better and cost significantly less than today’s ceramic and polymer options. Membrion is currently deploying this versatile technology to the rapidly growing desalination market, helping to address the global water crisis.

Modumetal™ is a revolutionary nanolaminated alloy that is stronger and lighter than steel and will replace conventional metals and composites in many applications, starting with military armor, and eventually in cars, planes, buildings, and other transportation and construction sectors.

Monod Bio is a pioneer company in the design of custom de novo protein-based biosensors that emit light when they recognize its target. Monod Bio’s innovative biosensor platform technology uses computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and cost-effective analytical assays. The company is founded on technology developed in David Baker’s group at the University of Washington’s Institute for Protein Design. Monod has been published in several peer-reviewed journals including Nature and Nature Biotechnology, shaping our understanding of scalable digital healthcare solutions. Monod Bio is based in Seattle, WA.

Founded in 2020 by a team of scientists led by Stephanie Berger based on research conducted at the Institute for Protein Design. The pre-clinical drug development company seeks to address Inflammatory Bowel Disease through de novo designed IL-23 receptor antagonists that are specifically designed to inhibit the IL-23/Th17 pathway which has been implicated in the pathogenesis of many chronic inflammatory disorders including IBD.

Olis Robotics is a software product company specializing in remote control of any robotic system through Olis CoreOS software platform.

Through the CoreOS platform, Olis is able to provide market specific robot solutions that leverage Olis’ proprietary machine perception and machine learning technologies. The goal of Olis’ technology is to provide supervised autonomy of industrial robots to drive higher levels of operational efficiency, deliver more robust safety measures and integration of digital management frameworks of the future.

World’s first receiver that combines the extreme bandwidth of direct sampling (2GHz instantaneous Nyquist bandwidth) with unprecedented high dynamic range.

Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming.

Phase Genomics’ mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.

Proniras Corporation is a biotechnology company focused on developing tezampanel as a potential treatment for opioid withdrawal and related disorders of addiction. Although effective treatments exist for opioid addiction, painful and difficult withdrawal is one of the reasons treatment fails and relapse occurs. By alleviating symptoms associated with opioid withdrawal, Proniras hopes to help patients complete their discontinuation of opioids and facilitate successful treatment. The development of tezampanel for opioid withdrawal is supported by federal funding from the National Institute on Drug Abuse (NIDA).

SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine’s high-throughput technology simultaneously tests more than 100 cancer drugs against a patient’s unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. The AI-optimized platform leverages the aggregated, anonymized test results to develop new cancer-fighting drugs.

Skytap is the leading provider of cloud-based virtual labs that deliver 100% self-service provisioning of complex IT environments without any architectural changes.

Better sense for the digital world

World’s first paper carbon nanotube capacitive sensors, highly sensitive to human presence, improving eye tracking, HMI, wearables and industrial safety.

We focus on the co-development of consumer and industrial products that improve health, interaction, and safety using our ground-breaking technology to transform the human experience.

The ThruWave team has developed a breakthrough millimeter wave sensor for use in cube utilization,  fulfillment, warehouse inventory management, retail shelf stocking, and manufacturing.

ThruWave’s headquarters is in Seattle, Washington, has over ten employees in North America, and we are growing fast!

​ThruWave’s expertise includes applied physics, electromagnetics, signal processing, and GPU computing applied to mmWave imaging and related mmWave radar system challenges.

Since 2007, TransformativeMed has built a reputation as a worldwide leader in Cerner EMR integration and innovation, leveraging the MPages development toolkit. Our innovative solutions have enabled more than 40 hospitals to maximize the value of their EMR investment. With Smart Health Apps from TransformativeMed, hospitals can focus on what matters most: patients, providers, and outcomes.

Tune Therapeutics is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment, and to unlock the full potential of regenerative medicine.

Solid tumor immunotherapies fail because of antigen heterogeneity, antigen escape and a suppressive tumor micro-environment.

Umoja is developing an integrated technology platform designed to cost effectively treat any tumor, any time …

Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space to design new molecular structures not found in nature.

Everyone Deserves a High Quality of Life. Watershed is Developing a Platform that Can:

• Provide treatment AND prophylaxis
• Provide acute AND chronic therapy
• Deliver LARGER drug payload
• Be tolerated better by patients
• Capture a far greater market

Ear aches are the pits. It’s never fun to see kids cranky, feverish, and pulling at their ears. And worst of all, it’s hard to tell if they need medication or just cuddles and rest.

With Wavely Diagnostic’s app, a standard mobile phone can tell if there is fluid in the ear that requires squeezing in a doctor visit, or if medication won’t help. With Wavely, you can be sure to treat every ear ache right.

WiBotic provides the most reliable wireless power and battery intelligence solutions to charge your aerial, mobile and aquatic robot systems.